Black Rock Inc. Myriad Genetics Inc Put Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MYGN
# of Institutions
230Shares Held
88.9MCall Options Held
43.5KPut Options Held
18.1K-
Vanguard Group Inc Valley Forge, PA10.6MShares$155 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$88 Million0.02% of portfolio
-
State Street Corp Boston, MA5.53MShares$81 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.18MShares$75.8 Million0.07% of portfolio
-
Earnest Partners LLC Atlanta, GA3.97MShares$58.2 Million0.25% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $1.18B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...